Generic name:tisagenlecleucel [ TIS-a-JEN-lek-LOO-sel ]
Drug class:Miscellaneous antineoplastics
What is Kymriah?
Kymriah is an immunotherapy medicine used to treat a certain type of acute lymphoblastic leukemia in people who are up to 25 years old.
Kymriah is also used to treat certain adult patients with large B-cell lymphoma.
Kymriah is given after other treatments have failed.
Kymriah is made using white blood cells removed from blood that is drawn from your body through a vein.
Kymriah is available under a special program. You must be registered in the program and understand the risks and benefits of this medicine.
Warnings
A serious side effect of Kymriah is called cytokine release syndrome, which causes fever, chills, trouble breathing, vomiting, and other symptoms. Your caregivers will have medication available to quickly treat this condition if it occurs.
Kymriah can also cause life-threatening nerve problems. Tell your caregivers or seek emergency medical attention if you have problems with speech, problems with thinking or memory, confusion, or a seizure.
Kymriah side effects
Get emergency medical help if you have signs of an allergic reaction to Kymriah: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
A serious side effect of Kymriah is called cytokine release syndrome (CRS). Tell your caregivers right away if you have signs of this condition: fever, chills, trouble breathing, body aches, vomiting, diarrhea, or feeling light-headed. Your caregivers will have medication available to quickly treat CRS if it occurs.
Also tell your caregiver...
